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PH domainMitochondria are central players in programmed cell death and autophagy. While phosphoinositides are well
established regulators of membrane trafﬁc, cellular signalling and the destiny of certain organelles, their
presence and role for mitochondria remain elusive. In this study we show that removal of PtdIns(4,5)P2 by
phosphatases or masking the lipid with PH domains leads to ﬁssion of mitochondria and increased
autophagy. Induction of general autophagy by amino acid starvation also coincides with the loss of
mitochondrial PtdIns(4,5)P2, suggesting an important role for this lipid in the processes that govern
mitophagy. Our ﬁndings reveal that PKCα can rescue the removal or masking of PtdIns(4,5)P2, indicating that
the inositol lipid is upstream of PKC.,5)bisphosphate; PtdIns, phos-
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Mitochondria are not just the powerhouse of the cell, but have also
an essential regulatory input into the cell's destiny. Apoptosis, the
programmed cell death, involves an increased permeability of the
outer mitochondrial membrane and subsequent loss of cytochrome
c that in turn will trigger the caspase cascades leading to the cell's
suicide [1]. Damaged organelles such as mitochondria can be
consumed by autophagy, which can precede apoptosis [2]. Cytosolic
components, includingmitochondria, are sequestered and enclosed by
a double membrane structure of unknown origin, called phagophore,
which when closed becomes an autophagosome [3]. Both apoptosis
and autophagy of mitochondria (mitophagy) have been indicated in
the development of cancer as well as neurodegenerative diseases and
have been therefore subject to many investigations [1].
Mitochondria, like the nucleus, are separated from the cytosol by a
double membrane system. Most lipids present in other compartments
such as phosphatidylserine, phosphatidylethanolamine, phosphati-
dylcholine, and phosphatidylinositol (PtdIns) are also found in
mitochondria [4]. While there is a wealth of information concerning
these lipids and their role in mitochondrial function, much less is
known about inositol lipids with respect to this organelle. Fromproteomic and lipidomic analyses it is evident that the mitochondria
contain PtdIns [4] and the higher phosphorylated phosphoinositides
[5] as well as their metabolising enzymes such as kinases, phospha-
tases and phospholipases [6]. Thus, the mitochondria seem to have all
the components to make or remove phosphoinositides such as PtdIns
(4,5)P2, yet nobody investigated whether PtdIns(4,5)P2 on the outer
mitochondrial membrane has a role in mitochondrial functioning,
integrity and destiny. In order to elucidate the potential role of this
particular lipid on the outer mitochondrial membrane, we employed
speciﬁc phosphatases and binding proteins to either remove or mask
the PtdIns(4,5)P2. Our data indicate that PtdIns(4,5)P2 plays a crucial
part in determining the destiny of mitochondria, bringing in a novel
dimension towards our understanding of mitochondrial destiny and
integrity.
2. Results
2.1. Loss of PtdIns(4,5)P2 on outer mitochondrial membrane leads to
fragmentation of mitochondria
In order to elucidate the role of PtdIns(4,5)P2 on the mitochondria
we ﬁrst constructed a plasmid with an outer mitochondrial localisa-
tion sequence that would target any protein exclusively to the
mitochondria. Tom20 is a major receptor of the mitochondrial pre-
protein translocation system and is bound to the outer mitochondrial
membrane (OMM) through the NH2-terminal transmembrane do-
main (TMD). It has been demonstrated that this TMD together with
positive charges at its proximal COOH-terminal ﬂanking region
targets GFP exclusively to the OMM in vivo [7]. We made use of this
approach to target the PtdIns(4,5)P2 speciﬁc 5-phosphatase Skip [8] to
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three different cell lines (MCF-7, HepG2 and NIH3T3) a green
ﬂuorescent mitochondrial network became visible (Fig. 1; EGFP),
which is similar to what has been described before as a “normal”
mitochondrial network in these types of cells [9,10]. Single mito-
chondria are elongated and occupy an average area of 1.5 μm2. The
cells are viable and divide at a normal rate. However, expression of
pOMML-Skip leads to a severe phenotype in all three cell lines. 24 h
after transfection the mitochondria appear fragmented with a
maximum cross-section area of 0.6 μm2 (Fig. 1; Skip) and after 48 h
only few ﬂuorescent mitochondria are visible and stably expressing
cell lines cannot be established (as opposed to mock transfected
cells). To test, whether this severe loss of Skip targeted mitochondria
occurs speciﬁcally due to the lack of PtdIns(4,5)P2 and/or is due to
the accumulation of PtdIns(4)P, we aimed to render PtdIns(4,5)P2
inaccessible without removing it. Therefore we overexpressed a
Pleckstrin Homology (PH) domain that speciﬁcally binds PtdIns(4,5)P2.
This approach should trap PtdIns(4,5)P2 and thusmake it unavailable as
a signallingmoleculewithout changing themembrane composition. The
PH domain of PLCδ1(PLCδPHd) is well known for its high afﬁnity to
PtdIns(4,5)P2 [11] and can be used to mask available PtdIns(4,5)P2
when overexpressed in cells [12]. When targeted to the mitochondria
(pOMML-PLCδPHd) transfected cells display punctiform, small, frag-
mented ﬂuorescent mitochondria and a complete loss of the mitochon-
drial network (Fig. 1; PLCδPHd). After 48 h only few ﬂuorescent
mitochondria remain and the cells are eventually detach (data not
shown). Furthermore, expression of a mutated PH domain, that was
shown not to bind the InsP3 headgroup anymore (pOMML-R37D) [13],
does not produce such a phenotype and the mitochondrial network
looks similar to mock transfected cells (Fig. 1; PLCδPHd-R37D).
Interestingly, targeting of the PLCδPHd to the inner mitochondrial
membrane with the commercially available pMito Vector does not
interferemuchwithmitochondrial integrity (Fig. 1; pMitoPLCδPHd) and
did not cause the severe loss of cells observedwith OMM targeting (data
not shown). The effects have been most pronounced in the MCF 7 cells,
which were subsequently employed to quantify the amount and size of
mitochondria with or without PtdIns(4,5)P2 capture or removal. As
shown in Fig. 2, introducing the PtdIns(4,5)P2 5-phosphatase SKIP or the
PtdIns(4,5)P2 capturing PH domain at the OMM drastically and
signiﬁcantly reduced the amount of mitochondria per cell, whereas the
IMMlocalisationof these tools hadno signiﬁcant effect (Student's t-test).
The reduction inmitochondrial numbers per cell was accompaniedwithFig. 1. Removal of PtdIns(4,5)P2 at the OMM causes fragmentation in mitochondria. MC
transfection of the indicated constructs. Cells expressing pOMML-EGFP (mock), pOMML-
(green). Transfection of pOMML-Skip or pOMML-PLCδPHd causes fragmentation of mito
representative of at least 3 independent experiments. NIH ﬁbroblasts showed similar respoan equally drastic and signiﬁcant reduction in the size of the
mitochondria, an effect that became more severe with time.
Taken together, these data (i) conﬁrm the importance of the
OMM localisation of PtdIns(4,5)P2, (ii) validate the distinct localisa-
tion of the two mitochondrial targeting vectors employed here,
(iii) demonstrate that PtdIns(4,5)P2 removal (Skip) and masking
(PH domain) are equally effective and ﬁnally (iv) imply an important
role for PtdIns(4,5)P2 on the outer mitochondrial membrane in
maintaining a healthy mitochondrial network.
2.2. Fragmentation of PtdIns(4,5)P2 deprived mitochondria does not
involve apoptotic cell death
Asmitochondria are at the centre of programmed cell death control,
we investigated whether the fragmentation and elimination of targeted
mitochondria were caused by apoptosis. The release of cytochrome
c from the mitochondrial intermembrane space is known to be a pro-
apoptotic event and thus cytochrome c release from themitochondria is
widely used as a marker for the loss of membrane integrity due to
apoptosis [14–19]). In order to investigate this cells (MCF7) were
depleted of their OMM PtdIns(4,5)P2 by targeting the PLCδPH domain
to this compartment, ﬁxed and then tested for cytochrome c release
by immunoﬂuorescence with an anti-cytochrome c antibody. This
approach reveals that the mitochondrial membrane is intact in both,
mock (empty vector) and pOMML-PLCδPHd transfected cells, as
cytochrome c is localised to the mitochondrial interspace (Fig. 3
inset), appearing in clearly deﬁned spots of mitochondrial shape (Fig. 3
in red), but clearly absent in the cytosol. For comparison, cells were
treated with Ionomycin to induce apoptosis (Fig. 3; 18 h/Ionomycin),
which indeed resulted in a diffuse cytosolic cytochrome c staining. In
contrast, mock transfected cells were devoid of cytosolic cytochrome c
staining, with all cytochrome c “spots” being surrounded by green
ﬂuorescence from the mitochondrial targeted EGFP (Fig. 3 inset).
Interestingly, upon targeting of green ﬂuorescent PLCδPHd to the
mitochondria, a signiﬁcant number of red-labelled intact mitochondria,
which do not display any green ﬂuorescence, appear (Fig. 3; 24 h/
PLCδPHd) and over time seem to prevail (Fig. 3; 48 h/PLCδPHd).
However, these cellswill eventually die, implying that the appearanceof
“wildtype” mitochondria is not sufﬁcient to overcome the process
initiated by the removal of PtdIns(4,5)P2. Nevertheless, due to the
absence of cytochrome c in the cytosol, it is clear that PtdIns(4,5)P2
deprived mitochondria fragment without losing their outer membraneF-7 cells (top) and HepG2 cells (bottom) were ﬁxed and immunostained 24 h after
PLCδPHd1R37D or pMito-PLCδPHd display a healthy, tubular mitochondrial network
chondria. The nuclei were counterstained with DAPI (false colour red). Images are
nses to the expression of these constructs (not shown).
Fig. 2. Measurement of mitochondria size and count. Cells were transiently transfected with speciﬁc mitochondrial targeted domains as described in Material and methods.
Deconvoluted ﬂuorescence microscopy images of mitochondria were masked and converted into a binary image. Particle size and count were measured using ImageJ software
(public domain, NIH Bethesda, Maryland, USA). A: An example of masks (middle) overlaying the mitochondria and binary image (right) of a control pOMML-PLCδPHd1R37D (top
row) and pOMML-PLCδPHd (bottom row) over-expressing human MCF-7 cell is shown. B: Particle size distribution of the shown example cells from (A). The horizontal mark
denotes the mean of all sizes (average size). C: Statistical analysis of mitochondria particle size and count measurements in randomly chosen ﬂuorescence positive cells MCF-7 cells.
Number of experiments (N=4–6); data are presented as means±SD. Statistical signiﬁcance of difference to the control (pOMML-EGFP) was assessed using Student's t-test
(* denotes pb0.05 and ** denotes pb0.01). 48 h measurements with pMito constructs n.d.
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we conclude that PtdIns(4,5)P2 depletion induced fragmenting of
mitochondria is not due to a loss of integrity associated with apoptosis.
2.3. Removal of mitochondrial PtdIns(4,5)P2 triggers autophagy
The exclusion of apoptosis prompted us to investigate whether
autophagic processes, which are characterised by digestion ofFig. 3. PtdIns(4,5)P2 depletion at the OMM is not causing cytochrome c release. MCF-7 cells w
the indicated times after transfection of pOMML-EGFP (green) or pOMML-PLCδPHd (gr
Cytochrome c is localised to the mitochondrial interspace, surrounded by mitochondria ou
overnight with 100 μM Ionomycin before ﬁxation followed by cytochrome c immunostaininmitochondria in acidic lysosomal compartments [20], are involved in
the PtdIns(4,5)P2 dependent mitochondrial fragmentation. To test
whether the degradation ofmitochondria observed after PtdIns(4,5)P2
removal through pOMML-Skip or masking through pOMML-PLCδPHd
is caused by autophagy, acidic compartments were stained with
lysotracker red (LTR), a well established marker for the lysosomal
compartment [21–23], and examined for co-localisation with mito-
chondria in HepG2 cells, a cell line that has been used successfullyere ﬁxed and immunostained with Alexa Fluor 594 (red) labelled anti-cytochrome c at
een). Counterstained with DAPI (blue) and examined by ﬂuorescence microscopy.
ter membrane targeted green ﬂuorescence (inset). For comparison, cells were treated
g (red).
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tion [24–26]. We found that mitochondrial fragmentation induced
by the expression of pOMML-Skip results in co-staining of mito-
chondria with acidic compartments, which is enhanced upon amino
acid starvation and glucagon stimulation (Fig. 4A). The same effect
was seen in pOMML-PLCδPHd transfected cells (data not shown)
conﬁrming the notion that removal of targeted mitochondria takes
place in acidic lysosomal compartments. The presence of LC3 in
autophagosomes (puncta formation) has been used as indicator of
autophagy [27]. Immunoﬂuorescence of LC3 with an antibody
revealed red puncta formation and co-staining with fragmented
mitochondria in pOMML-Skip expressing cells (Fig. 4B; Skip)
indicating the formation of autophagosomes induced by removal of
PtdIns(4,5)P2. Puncta did not appear in mock transfected cells
(Fig. 4B; EGFP).
3-Methyladenine (3-MA) has been used to inhibit autophagy [28].
It is a class III PI3-kinase inhibitor that has been used to block the
formation of the autophagosome, a process that seems to depend on
the presence of PtdIns(3)P [29]. Fig. 4C reveals that 3-MA treatment
does not inhibit the fragmentation of mitochondria in pOMML-
PLCδPHd transfected cells. Similar effects were observed in pOMML-
Skip treated cells, whereas in mock transfected cells 3-MA did not
inﬂuence the amount of mitochondria (data not shown). As 3-MA
inhibits the formation of the autophagosomes, we conclude that
fragmentation of mitochondria caused by PtdIns(4,5)P2 loss precedes
autophagy, rather than it being an effect of lysosomal degradation of
mitochondria [30].Fig. 4. Removal of mitochondrial PtdIns(4,5)P2 leads to fragmentation and mitophagy. A: 24
(right panel), while control cells (left panel) were kept in normal growth medium. HepG2 ce
DAPI (cyan). Acidic compartments (red) that co-localise with mitochondria (green) appear
mitochondria do not localise with them. Upon induction of autophagy through amino acid sta
pOMML-Skip transfected cells (lower panel) have fragmentedmitochondria with andwithou
amino acid starvation and glucagon stimulation. B: Immunoﬂuorescence of LC3. 16 h after t
(red) and DAPI counterstained (cyan). Punctuate staining of LC3 indicates sites of autophago
transfected cells (Skip). Puncta formation is absent in pOMML-EGFP transfected cells (EGFP)
and NIH cells were transfected with pOMML-PLCδPHd (green). After 12 h growth medium w
12 h cells were ﬁxed, DAPI (cyan) counterstained and observed under the microscope. Fragm
cells as compared to untreated pOMML-PLCδPHd transfected cells (left).2.4. Mitochondrial PtdIns(4,5)P2 loss in glucagon induced autophagy
The data suggest that PtdIns(4,5)P2 loss is causing fragmentation,
which is then followed by a process consistent with autophagy.
However, it remained to be determined whether the induction of
autophagy under physiologic conditions would also exhibit a loss of
PtdIns(4,5)P2 on the mitochondrial membrane. It is well established
that autophagy can be induced in HepG2 cells by amino acid
starvation and glucagon induction [24–26,31]. Thus, it would be
possible to exploit these conditions for HepG2 cells to correlate PtdIns
(4,5)P2 on the OMMwith autophagy. In order to obtain the lipid levels
on the OMM, isolated mitochondria were probed with a recombinant
GST-tagged PLCδPHd, a lipid recognition domain that is frequently
employed to detect speciﬁcally PtdIns(4,5)P2 in overlay assays and
microscopy [8,32–35]. Here, we utilize the recombinant GST-tagged
PLCδPHd in a pull-down with isolated mitochondria from hepato-
cytes, where the amount of captured recombinant PLCδPHd should be
a direct indicator of the PtdIns(4,5)P2 levels on the OMM. Importantly,
our data (Fig. 5C and D) validate the usefulness of this approach, since
stripping off the phosphates of the inositol lipids by the speciﬁc
inositol phosphatase Synaptojanin [36,37] abolished the pull-down of
the recombinant PLCδPHd domain. This method could therefore
speciﬁcally monitor organelle PtdIns(4,5)P2 levels and was subse-
quently employed to evaluate the PtdIns(4,5)P2 levels on the OMM of
isolated mitochondria from HepG2 cells that had been amino acid
starved and glucagon treated in order to induce autophagy. For
comparison, isolated mitochondria from cells that were kept inh after transfection, HepG2 cells were amino acid starved and glucagon induced for 1 h
lls were then treated with lysotracker red (LTR), washed, ﬁxed and counterstained with
yellow. Mock transfected cells (upper panel) have only a few acidic compartments, but
rvation (right panel) mitochondria become fragmented and co-localise with lysosomes.
t starvation and co-localise with acidic compartments. The phenotype is enhanced upon
ransfection HepG2 cells were ﬁxed and immunostained for the autophagy marker LC3
some formation which partly co-localise with fragmentedmitochondria in pOMML-Skip
. Images from two independent experiments are shown (left and right, resp.). C: HepG2
as supplemented with the autophagy inhibitor 3-MA or solvent control. After another
ented mitochondria accumulate in 3-MA treated pOMML-PLCδPHd (right) transfected
Fig. 5. Mitochondrial PtdIns(4,5)P2 loss in amino acid starved/glucagon treated HepG2 cells. Mitochondria from +/−autophagy (AA starvation+glucagon) induced HepG2 cells
were probed with recombinant GST-PLCδPHd that speciﬁcally binds PtdIns(4,5)P2. A: After stringency washes, lysates were subjected to SDS-PAGE and the gel was Coomassie
stained. B: Western blot analysis of the same lysates with anti-GST antibody conﬁrms that mitochondria isolated from cells in full medium (control) were recovered with more GST-
PLCδPHd bound, indicating a loss of PtdIns(4,5)P2 during physiologic autophagy (42.45+/−2.85% of control PIP2 levels; mean and standard error for 2 independent experiments).
C: To validate that PtdIns(4,5)P2 can be detected with a recombinant GST-tagged PLCδPHd isolated mitochondria were stripped (30 min) of their PtdIns(4,5)P2 with a recombinant
catalytic subunit of Synaptojanin 1 (a PtdIns(4,5)P2 5-phosphatase). For comparison the corresponding inactive enzyme, was employed. GST-tagged recombinant PLCδPHdwas then
added to both washed samples and the mitochondria were washed again and sedimented. The recovered mitochondrial pellet was lysed and subjected to SDS-PAGE (Coomassie
stain). The triangle indicates the position of the PLCδPHd. The ﬁrst lane reveals the purity of the PLCδPHd preparation. D: The same lysates were also subjected to Western blotting.
Blots were probed with anti-GST antibodies for the amount of mitochondria-bound PLCδPHd, which in turn correlates with the amount of PtdIns(4,5)P2 present on the OMM. Indeed,
less PLCδPHdwas detected in the sample treated with active Synaptojanin, indicating that PtdIns(4,5)P2 is present on themitochondrial membrane, readily accessible for PtdIns(4,5)
P2 metabolising enzymes. Importantly, these data indicate that the PLCδPHd can be used as a tool to speciﬁcally detect PI(4,5)P2 on the mitochondrial membrane.
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reveal a substantial loss of PtdIns(4,5)P2 levels in mitochondria
undergoing amino acid starvation (Fig. 5A and B), which implies that
PtdIns(4,5)P2 levels in the OMM are an important element in the
signalling controlling autophagy.
2.5. PKCα inhibition mimics the phenotype caused by mitochondrial
PtdIns(4,5)P2 removal
We have shown that mitochondrial PtdIns(4,5)P2 levels are
reduced during amino acid starvation induced autophagy and thus
have established its presence in the signalling leading to autophagy. It
is clear that the loss of PtdIns(4,5)P2 caused by the phosphatases
could impair other PtdIns(4,5)P2 metabolising enzymes such as
the PI-PLC or the PtdIns(4,5)P2 dependent PLD. In order to elucidate
this, we focused on chemical inhibitors that are known to interfere
with PtdIns(4,5)P2 dependent pathways as well as being able to
cause mitochondrial phenotypes. Cells were treated with a series
of compounds acting as Ca2+ ionophore, Ca2+ chelator, PC-PLD
inhibitor, PC-PLC and cPLA(2) inhibitor, PI-PLC inhibitor, PI3-kinase
inhibitor or PKC inhibitors (data not shown) and examined for
mitochondrial size and shape changes using ﬂuorescence microscopy
imaging. It became apparent that calcium and/or PKC may play a role,
which prompted a further investigation of this matter. Fig. 6A shows
that long-term incubation of MCF-7 cells with the phorbolester PMA
(12-O-tetradecanoylphorbol 13-acetate), which is known to cause
downregulation of PKCα, δ and ε [38,39], leads to fragmentation of
mitochondria. Mitochondria in control cells showed an average
fragment size of 2.3 μm2, whereas in PMA treated or pOMML-PLCδPHd
expressing cells showed an average fragment size of 0.4 μm2. Similar
or synergistic effects were seen with Bapta AM, a Ca2+ chelator (data
not shown). As PKCε is not Ca2+ dependent and Rottlerin, a PKCδ-
inhibitor, did not cause such a phenotype (data not shown), we
hypothesised that the sensing of PtdIns(4,5)P2 deprivation on the
mitochondrial membrane is PKCα mediated.
In order to test this hypothesis, we examined mitochondrial
lysates by Western blotting with an antibody that recognises
speciﬁcally the motif that conventional PKCs (cPKC) phosphorylate
[40]. This phospho-(serine) PKC substrate antibody has been shown
to detect endogenous levels of known and unknown proteins, whenphosphorylated at serine residues surrounded by arginine or lysine at
the −2 and +2 positions and a hydrophobic residue at the +1
position [41]. We used mitochondrial lysates from MCF-7 cells that
had been transfected with pOMML-PLCδPHd (70% of cells were GFP
positive as judged by ﬂuorescence microscopy), pOMML-EGFP control
cells, chelerythrine chloride (a selective inhibitor of group A and B PKC
isoforms) [42] treated cells and amino acid starved cells. Fig. 6B shows
that PKC serine substrates are less phosphorylated in mitochondria
from autophagy induced cells (pOMML-PLCδPHd transfectants
and amino acid starved cells) and chelerythrine chloride-treated
cells. The most striking difference is a phosphorylated 35 kDa sub-
strate, which can only be detected in control mitochondrial lysates
and is completely absent from autophagy induced cells. Notably,
despite loading of equal amounts of total protein, mitochondria
from chelerythrine chloride-treated cells seem to be driven towards
apoptosis, as less cytochrome c, is present in mitochondrial lysates.
Taken together, PtdIns(4,5)P2 removal reduces PKC activity on
mitochondria. It is evident that loss in cPKC substrate phosphorylation
is a common hallmark of PtdIns(4,5)P2 removal and starvation
induced autophagy. The sensitivity of this process to calcium and
PKC modulating agents as well as the PKC isozyme speciﬁc inhibition
by chelerythrine chloride points to PKCα as the main downstream
target.
2.6. Co-expression of mitochondrial targeted PKCα and PtdIns(4,5)P2
phosphatase Skip rescues from mitophagy
If PKCα is the downstream signal of reduced PtdIns(4,5)P2 levels
in cells undergoing autophagy, the overexpression of PKCα at the site
of PtdIns(4,5)P2 deprivation may rescue such a phenotype. We
therefore constructed a DsRed tagged full-length PKCαwith the same
localisation signal as for the PtdIns(4,5)P2 modulation tools used
earlier and transfected it at the same time as the EGFP tagged pOMML-
Skip. In cells that were co-expressing both constructs we found that
pOMML-DsRed-PKCα inhibits fragmentation of mitochondria and the
cells survive (Fig. 6C). pOMML-DsRed mock vector does not change
the phenotype caused by pOMML-EGFP-Skip. These data conﬁrm that
PKCα is an effector of PtdIns(4,5)P2 dependent mitophagy and that its
mitochondrial overexpression rescues mitochondria from fragmen-
tation and consequently from elimination by autophagy.
Fig. 6.Mitophagy induced by masking PtdIns(4,5)P2 can be rescued by PKC. A: Overexpression of the PtdIns(4,5)P2 binding domain PLCδPHd on the outer mitochondrial membrane
results in fragmentation of mitochondria soon after expression and leads to mitophagy as outlined above (left). PMA long-term treatment also results in mitochondrial
fragmentation (middle), whereas treatment with solvent control has no effect on the mitochondrial network and mitochondria keep a tubular shape (right). Insets: automatic area
recognition (IPLab Software) shows single fragments encircled. Mitochondria were stained with an Alexa Fluor 594 labelled cytochrome c antibody. B: Detection of phospho-serine
PKC substrates in mitochondrial lysates. MCF-7 cells were transfected with pOMML-PLCδPHd (lane PHD) or pOMML-EGFP (lane MOCK) and mitochondria were isolated 24 h after
transfection. Mitochondria were also isolated from MCF-7 cells that had been treated with PKC inhibitor chelerythrine chloride (lane CHEL) or amino acid starved (lane AA).
Mitochondria were lysed and subjected to Western blotting. The membrane was probed with anti phospho-serine PKC substrate antibody (top). Anti cytochrome c was used as a
loading control on the stripped membrane (bottom). PHD and AA have signiﬁcantly decreased phospho PKC substrate levels comparable to negative control CHEL. Compared to
MOCK control mitochondria from autophagy induced cells (PHD and AA) are lacking phosphorylated 35 kDa substrate and phosphorylation of 50 kDa, 75 kDa and 105 kDa
substrates is reduced. Chelerythrine chloride treatment inhibits phosphorylation, but mitochondria are leaking cytochrome c, as can be seen from the faint band, despite loading
equal amounts of protein. C: Co-expression of mitochondrial targeted PKCα and PtdIns(4,5)P2 phosphatase Skip. 24 h of pOMML-Skip overexpression leads to fragmentation of
mitochondria (green dots) and consequently to mitophagy. Co-expression of the pOMML-DsRed empty Vector does not change this phenotype (left). Co-expression of pOMML-
PKCα (red) inhibits fragmentation of 5-phosphatase “attacked” mitochondria and cells display a mitochondrial network with co-localised PKCα (co-localisation appears yellow)
(right). Nuclei were counterstained with DAPI.
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Before this study, little was known of the role played by the
mitochondrial membranes and their phospholipid constituents. It is
proven that PtdIns is present in theOMM[43] and immunogold labelling
has also implied the presence of PtdIns(4,5)P2 [5]. However, regulation
of mitochondrial phosphoinositides and their speciﬁc function has been
neglected, partly because of difﬁculties in measuring these lipids.
Here we present evidence that PtdIns(4,5)P2 is present on the outer
mitochondrial membrane. Firstly, recombinant PLCδPHd domain, which
binds speciﬁcally to the headgroup of PtdIns(4,5)P2, could be recovered
from isolatedmitochondria that had been probedwith the recombinant
PH domain (Fig. 5). Secondly, the expression of the phosphatase Skip,
which speciﬁcally dephosphorylates PtdIns(4,5)P2 [36], on the OMM
leads to a severe phenotype change of mitochondria, indicating an
important function for this lipid in mitochondria. Since PtdIns(4,5)P2
binding and metabolising proteins have been found on mitochondria
[6,44,45], it is not surprising thatmitochondria havePtdIns(4,5)P2 on the
outer membrane. But the question is whether PtdIns(4,5)P2 is only a
structural part of the mitochondrial membrane, or whether it also has
an important signalling function, similar to PtdIns(4,5)P2 on the plasma
membrane.
We conclude that mitochondrial PtdIns(4,5)P2 is an important
signalling molecule, rather than a structural component.
We show that [36] masking of PtdIns(4,5)P2 by overexpression of
OMM targeted PLCδPHd creates fragmented mitochondria (Fig. 1).The same effect is seen when the lipid is removed by dephosphory-
lation through the PtdIns(4,5)P2 speciﬁc 5-phosphatase Skip. While
employing the PH domain renders the headgroup of PtdIns(4,5)P2
invisible for signalling molecules on the OMM, such as Synaptojanin 2A
[45], without changing the membrane composition, the 5-phosphatase
would effectively alter membrane composition by converting PtdIns
(4,5)P2 into PtdIns(4)P. Yet both methods create the same phenotypes
leading to the conclusion that mitochondrial PtdIns(4,5)P2 is an
important signalling molecule, rather than a structural component of
themembrane.On the contrary, overexpressionof thePHdomainon the
inner mitochondrial membrane has no detectable mitochondrial
phenotype, hinting that either PtdIns(4,5)P2 has no signalling func-
tion there or the innermembrane is devoid of this lipid. The latterwould
not be surprising, considering that it is generally believed that the inner
membrane is a relic of endosymbiontic origin [46,47] and thus
resembling a prokaryotic membrane in composition.
Investigating the role of mitochondrial PtdIns(4,5)P2 demonstrat-
ed its importance for organisation of mitochondrial network in the
cell. The loss or masking of this lipid resulted in the fragmentation of
mitochondria, which was then followed by autophagy, as judged from
co-localisation with lysosomes and LC3 staining (Fig. 4) [26]. This
prompted the question whether “naturally” (nutrient deprivation)
triggered autophagy would correlate with changes in mitochondrial
PtdIns(4,5)P2 levels. Indeed, we discovered that PtdIns(4,5)P2 levels
are greatly reduced during autophagy that has been triggered through
nutrient deprivation (Fig. 5), indicating that PtdIns(4,5)P2 acts as an
484 E. Rosivatz, R. Woscholski / Cellular Signalling 23 (2011) 478–486important component of themachinery controlling the events leading
to autophagy in general. In essence one could perceive mitochondrial
PtdIns(4,5)P2 levels as a maintenance indicator for mitochondria, but
it is also possible that this inositol lipid is a precursor to other lipid
mediators that may be participating in this process.
For that reason, we probed known PtdIns(4,5)P2 dependent
pathways by pharmacological proﬁling of our phenotype. Our results
indicated an involvement of calcium and PKCs prompting us to
investigate the role of the classical (calcium dependent) PKCs in
PtdIns(4,5)P2 dependent induction of mitochondrial fragmentation.
Employing a speciﬁc antibody recognising the phospho-serine motifs
phosphorylated by classical PKCs revealed that mitochondrial lysates
from cells that had been PtdIns(4,5)P2 deprived or amino acid starved
contained less PKC-phosphorylated proteins (Fig. 6).
It is clear that PtdIns(4,5)P2 removal on the mitochondria could
result in the reduction of PI-PLC second messenger products, DAG and
Ins(1,4,5)P3, which are needed for the activation of classical PKC
isoenzymes. Indeed, PLCδ-1 has been found to be present on the
mitochondria to regulate mitochondrial calcium uptake in liver cells
[44]. Furthermore, we could induce mitochondrial fragmentation in
MCF-7 cells with the selective PLC inhibitor U-73122, but not with the
inactive analogue U-73343 (data not shown). Recently, it was
demonstrated that the isoenzyme PKCα translocates to the mitochon-
dria inmyocytes upon PMA treatment [48], and the C2 domain of PKCα,
which binds directly to PtdIns(4,5)P2, has been shown to be important
for the localisation and activity of this enzyme [49].We reasoned that in
both cases, overexpression of mitochondrial targeted PKCα should
rescue the PtdIns(4,5)P2 deprivedmitochondria, if a cPKC substratewas
the signal that protects the mitochondrion from the autophagic
machinery when phosphorylated. We found that overexpression of
mitochondrial targeted full-length PKCα did indeed rescue PtdIns(4,5)
P2 deprived mitochondria from mitophagy, indicating that the interac-
tion between PtdIns(4,5)P2 and PKCα sufﬁces for its activation on the
mitochondria, because we did not use a constitutively active enzyme.
In summary, this result indicates that PKCα a well established
mitochondrial PKC isoform that controls apoptosis [50], is also an
important mediator in PtdIns(4,5)P2 deprivation induced fragmenta-
tion and mitophagy.
4. Material and methods
4.1. Tissue culture
NIH 3T3 mouse ﬁbroblasts and MCF-7 human breast cancer cells
were grown in DMEM supplemented with 10% foetal calf serum (FCS)
(Gibco-Invitrogen), and HepG2 cells were grown in Minimal Eagle's
Medium supplemented with 10% FCS, glutamate (Sigma, G7513) and
non-essential amino acids at 37 °C in an atmosphere of 5% CO2. For
amino acid starvation, cells were cultured in serum-free Krebs–
Ringer-HEPES buffer (KRH: 25 mM HEPES, 115 mM NaCl, 5 mM KCl,
1 mM KH2PO4, 1.2 mM MgSO4, and 2 mM CaCl2, pH 7.4 at 37 °C)
containing 1 μM glucagon (Sigma, G3157). In some experiments,
10 mM 3-MA (Sigma, M9281) was added 30 min before and again
during autophagic induction. Media and supplements for cell culture
were purchased from Sigma-Aldrich unless otherwise stated. Cell
lines were obtained from ATCC.
4.1.1. Other inhibitors and reagents
The following concentrationswere used: 10 μMU73122 (Calbiochem,
662035), 40 μM Bapta AM (Calbiochem, 196419), 100 μM Ionomycin
(Calbiochem, 407950), 100 nM PMA (Calbiochem, 524400), 50 μM
LY294002 (Calbiochem,440202), 10 μMRottlerin (Calbiochem,557370),
200 μM D609 (Calbiochem, 251400), and 0.4% n-Butanol (Sigma,
B7906). Solvent controls: DMSO (Sigma, D2650) and 10 μM U73343
(Calbiochem, 662041).4.2. Transfection
Cells were cultured in 24-well plates (containing 500 μl medium per
well) on glass coverslips and transfected at 70% conﬂuence. 0.5 μg
plasmidDNAwasdiluted in50 μl serum-freemediumand1 μl Turbofect
(Fermentas, R0531) was added. The transfection mixture was allowed
to stand for 20 min before it was added to the cells. The transfectants
were analysed 24 h after transfection unless speciﬁed differently.4.3. Plasmids
Inner mitochondrial membrane localisation Vector: A Kozak
sequence followed by the mitochondrial targeting sequence derived
from the precursor of subunit VIII of human cytochrome c oxidase
targeting sequence from the commercially available pAcGFP1-Mito
was cloned directionally in frame between the NheI and AgeI
restriction sites at the N-terminus of the ﬂuorescent protein coding
sequence of commercially available pEGFP-C1 (pMito, mock control).
The original in frame restriction sites of the multiple cloning sites
were used to insert Skip full-length phosphatase.
Outer mitochondrial membrane localisation Vector: A Kozak
sequence followed by the minimal targeting sequence from the
mitochondrial import receptor TOM20 (CAGCGTTGTAGCTAGCAT-
GGTGGGTCGGAACAGCGCCATCGCCGCCGGTGTATGCGGGGCCCTTTT-
CATTGGGTACTGCATCTACTTCGACCGCAAAAGACGAAGTGACCC-
CAACTTCAAGAAACCGGTTTAGAG) was cloned directionally in frame
between the NheI and AgeI restriction sites at the N-terminus of the
ﬂuorescent protein coding sequence of commercially available
pEGFP-C1 (pOMML for outer mitochondrial membrane localisation)
or pDsRed-Express (pOMML-DsRed) (mock controls), respectively.
The original in frame restriction sites of the multiple cloning sites
were used to insert the proteins of interest: PH domain of PLCδ-1
(PLCδPHd), PLCδPHd R37D, Skip, and PKCα, respectively.
PLCδPHd was mutated to PLCδPHdR37D by site directed muta-
genesis using the sense primer 5′-gaagtccagctcgtgggatagggaacgcttc-
tac-3′ and antisense primer 5′-gtagaagcgttccctatcccacgagctggacttc-3′.
pAcGFP1-Mito (PT3730-5), pEGFP-C1 (PT3028-5), and pDsRed
(PT3678-5) were purchased from BD Biosciences Clontech. Human
cDNA clone TOMM20 (accession no. NM_014765.1; order number
SC114860) was purchased from OriGene Technologies. NheI and AgeI
restriction sites, ﬂanking the targeting sequence, were introduced
by PCR using the following primers 5′-cagcgttgtagctagcatggt-3′ and
5′-ctctaaaccggtttcttgaagt-3′.
All constructs were propagated in E. coli XL1-Blue (Stratagene,
200268), isolated with Qiagen Maxiprep and veriﬁed by sequencing
(Yorkshire Biosciences).4.4. Microscopy and image analysis
Cell preparations were observed under a Nikon TE 2000 ﬂuores-
cence microscope using a 100× Fluor oil lens. Filters used in the
ﬂuorescence experiments were band pass for DAPI, FITC and TRITC
with excitation wavelength of (nm) 340–380, 465–495 and 540–580,
respectively, and with emission wavelength of (nm) 435–485, 515–
555 and 572–605, respectively. Images were digitally acquired with a
CCD camera (Hamamatsu) for each ﬂuorophore separately and pro-
cessed using IPLab software v 3.65a and ImageJ (National Institutes of
Health, Bethesda, MD).
Analysis of fragmentation of mitochondria by microscopy was
carried out with the automatic particle size recognition tool of ImageJ
software (public domain, NIH Bethesda, Maryland, USA). Fluorescence
microscopy images of mitochondria were masked and converted into a
binary image. Particle size and countweremeasured using an exclusion
area (area occupied by a single mitochondrial fragment) of N0.6 μm2.
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Cells were ﬁxed in 4% (w/v) PFA for 10 min, quenchedwith 50 mM
NH4Cl/PBS, permeabilized with 0.1% (v/v) Triton X-100 for 7 min and
blocked with 1% (w/v) BSA/PBS (fatty acid free; Sigma, A6003) for 1 h
at room temperature. Cells were then incubated with the ﬂuores-
cently labelled antibody (1:200 diluted in blocking solution) for 1 h
followed by three extensive PBS washes before treatment with
300 nM 4′,6-diamidino-2-phenylindole (DAPI; Calbiochem, 268298)
for nuclear counter staining. Thoroughly washed coverslips were
mounted on glass slides using Mowiol supplemented with 0.6% (w/v)
1,4-diazabicyclo-[2.2.2]octane (DABCO). Cytochrome c antibody (BD
Pharmingen, 556432) and LC3 antibody (Cell Signaling, 2775) were
labelledwith an appropriate Alexa ﬂuor dye using the Zenon Antibody
labelling kit (Invitrogen, Z-25005).
4.5.1. Loading of lysotracker red (LTR)
500 nM LTR (Invitrogen, L-7528) was added to the living cells for
20 min. Then cells were washed twice with PBS and ﬁxed with 4%
paraformaldehyde. Coverslips were mounted as described earlier. JC-1
staining (Sigma, T4069)was carried out according to themanufacturer's
instructions and mitochondria were checked under the microscope
for bright red ﬂuorescence. Control samples were pretreated with
valinomycin.
4.6. Mitochondria extraction with a Parr Cell Bomb (45 ml)
Adherent cells were washed twice, harvested in ice cold PBS and
pelleted at 500×g for 5 min. The cell pellet was resuspended in an
equal volumeof cold cavitation buffer (250 mMsucrose, 20 mMHepes
pH=7.5, 2 mMMgCl2, 1 mMNaEDTA, 1 mMPMSF, 1 mMDTT),which
contained 5 μM pV(phenbig) [33] and a Protease Inhibitor Cocktail III
(Calbiochem, 539134), and transferred to the pre-chilled cavitation
bomb [51]. The chamber was pressurised at 300 psi and incubated on
ice for 5 min before the pressure was slowly released. The recovered
suspensionwas checked in themicroscope for efﬁcient cell disruption.
All following stepswere carried out in the cold or on ice. The lysatewas
cleared of nuclei and debris at 500×g. The pelletwas discarded and the
supernatant was centrifuged 3 times (each time transferred to a fresh
tube) at 1300×g for 5 min. Then the supernatant was split into 300 μl
aliquots and centrifuged at 14000×g for 20 min. The pellet was
resuspended in a desired volume of cavitation buffer and analysis of
mitochondria was carried out. Alternatively the suspension was
supplemented with 50% glycerol for storage at −80 °C. The quality
of the mitochondria was checked by microscopy and JC-staining [52]
revealing a greater than 95% purity and integrity (data not shown).
4.7. Protein expression
pGEX-4T1 containing the PLCδPHd or the catalytic subunit of
Synaptojanin, respectively[36], was transformed into E. coli XL1-Blue.
A single colony was picked transferred into 5 ml of LB-medium and
shaken at 37 °C. The culture was subsequently scaled up to 4 l. Protein
expressionwas inducedby100 μMisopropyl-b-D-thiogalactopyranoside
(IPTG, Sigma, 59740) addition and incubation at 18 °C overnight.
Glutathione S-transferase (GST)-fusion protein was puriﬁed according
to the manufacturer's manual using glutathione-Sepharose 4B (GE
Healthcare, 17-07-56-01). Protein integrity was conﬁrmed by Western
blot using a GST antibody (Novagen, 71097).
4.7.1. Western blotting
Mitochondria were lysed in SDS sample buffer, boiled and
separated by SDS-PAGE and blotted on PVDF membrane. After
blocking in 5% (w/v) milk, membranes were probed with a primary
antibody, followed by a secondary HRP conjugated antibody. The GST
antibody was used at a 1:1000 dilution whereas the PKC phospho-serine substrate antibody (Cell Signaling, 2261) was used at 1:200.
HRP secondary antibody conjugates (Bio-Rad, 172–1019) were
employed at 1:5000. Quantiﬁcation of band densities was carried out
with ImageJ software.
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